STOCK TITAN
  1. Home
  2. Sec-filings
  3. CLX
  4. [Form 4] CLOROX CO /DE/ Insider Trading Activity

CLX exec tax-withholding of 622 shares at $122.25; ownership 27,895

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Nina Barton, EVP-Group Pres–Care & Conn at Clorox Co. (CLX), reported a sale of 622 shares of Clorox common stock on 10/03/2025 at a price of $122.25 per share. The transaction is recorded as code F and is explained as withholding of shares to satisfy tax obligations related to the vesting of restricted stock. After the transaction, Ms. Barton beneficially owns 27,895 shares, which includes 21 shares acquired via a dividend reinvestment feature of the Company’s Stock Incentive Plan.

The report was signed by an attorney-in-fact on 10/07/2025. The filing indicates a routine tax-withholding disposition rather than an open-market sale, and it shows continued significant insider ownership by an executive responsible for the company’s care and consumer connections businesses.

Positive

  • Timely disclosure of the transaction under Section 16
  • Withholding used to satisfy tax on RSU vesting rather than an open-market sale
  • Significant continued ownership of 27,895 shares after the transaction

Negative

  • Reduction in direct holdings by 622 shares
  • Potential near-term vesting events could cause additional small dispositions for tax withholding

Insights

Sale reflects tax withholding from RSU vesting, not an opportunistic market exit.

The 622-share disposition is annotated as a withholding to satisfy tax obligations tied to restricted stock vesting, which is a common administrative step after equity grants vest. The transaction price is $122.25, and the method (code F) aligns with company-administered tax withholding.

This action reduces the reported direct holding to 27,895 shares including 21 DRIP shares; monitor future vesting schedules or additional withholding events within the next 12 months for further small changes in share count.

Timely disclosure and continued insider ownership support governance transparency.

The form shows the reporting person is an executive officer and the filing is by one reporting person, indicating individual reporting responsibility. The form was executed by an attorney-in-fact, which is permissible when properly authorized.

Investors may note the executive still holds a meaningful stake of 27,895 shares; check future Section 16 filings for executives to track concentrated ownership or patterned open-market transactions over 12 months.

Insider Barton Nina
Role EVP-Group Pres-Care & Conn
Type Security Shares Price Value
Tax Withholding Common Stock 622 $122.25 $76K
Holdings After Transaction: Common Stock — 27,895 shares (Direct)
Footnotes (1)
  1. Withholding of shares by the Company to satisfy tax obligations relating to vesting of restricted stock. Includes 21 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Barton Nina
(Last) (First) (Middle)
1221 BROADWAY
(Street)
OAKLAND CA 94612-1888
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP-Group Pres-Care & Conn
3. Date of Earliest Transaction (Month/Day/Year)
10/03/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/03/2025 F(1) 622 D $122.25 27,895(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Withholding of shares by the Company to satisfy tax obligations relating to vesting of restricted stock.
2. Includes 21 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan.
By Jinho Joo, Attorney-in-Fact 10/07/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What transaction did the Clorox insider (CLX) report on 10/03/2025?

The filing reports a disposition of 622 shares on 10/03/2025 at $122.25 per share, recorded as tax withholding related to restricted stock vesting.

Who is the reporting person on the Form 4 for CLX?

The reporting person is Nina Barton, EVP-Group Pres–Care & Conn, listed as an officer of Clorox Co. (CLX).

How many Clorox shares does Nina Barton own after the reported transaction?

She beneficially owns 27,895 shares following the transaction, which includes 21 shares from a dividend reinvestment feature.

Why were the shares disposed of according to the filing?

The filing explains the shares were withheld by the company to satisfy tax obligations arising from the vesting of restricted stock.

Was the Form 4 signed by the reporting person?

The form was executed by an attorney-in-fact, Jinho Joo, on 10/07/2025, as indicated in the signature block.